Clayman Michael D. 4
4 · Flexion Therapeutics Inc · Filed Jul 20, 2021
Insider Transaction Report
Form 4
Clayman Michael D.
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2021-07-19−13,859→ 334,981 total
Holdings
- 388,683(indirect: By LLC)
Common Stock
- 373,769(indirect: By Trust)
Common Stock
- 24,600(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Withholding of shares by the Issuer to satisfy income tax obligations associated with the vesting of a restricted stock unit award granted to the Reporting Person on July 16, 2020.
- [F2]Shares held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.